ABSTRACT
BACKGROUND: Dementia is becoming a significant public health concern, affecting approximately 130,000 individuals in Austria, whereby nearly 40% of the cases are attributed to modifiable risk factors. Multidomain lifestyle interventions have thereby demonstrated significant effects in reducing the risk of dementia. OBJECTIVES: The goal was to define an interoperability framework to conduct standardized monitoring in clinical trials for enhancing dementia risk mitigation. In addition, the identified standards should be integrated into the components of the project. METHODS: A step-by-step approach was used, where initially data collection, aggregation and harmonization was carried out with retrospective data from various clinical centers. Afterwards, the interoperability framework was defined including the prospective data that is gathered during a clinical trial. RESULTS: A guideline for integrating healthcare standards was developed and incorporated into the technical components for the clinical trial. CONCLUSION: The interoperability framework was designed in a scalable way and will be regularly updated for future needs.
